Marina Ahmad is an associate in the firm’s Business Law Department and a member of its Life Sciences group. Her practice focuses on the representation of start-up and later-stage companies across the full corporate life cycle, including formation matters, venture capital financings, mergers and acquisitions, securities offerings and general corporate representation and counseling.

Ms. Ahmad is also a member of the Board of Trustees of Muslims with Progressive Values, a nonprofit organization advocating for human rights, social justice, and inclusion in the United States and around the world.

Areas of Practice
Domaines D’Expertise





A selection of Ms. Ahmad’s recent representations include:

  • BridgeBio Pharma in its sale of NULIBRY™ (Fosdenopterin) for Injection to Sentynl Therapeutics
  • Arkuda Therapeutics, Inc. in its $64 million preferred stock financing
  • Questa Capital Partners in its investment in Vynca 
  • Convergent Dental, Inc. in its $40 million preferred stock financing
  • BIOMILQ, Inc. in its $21 million preferred stock financing 
  • Relay Therapeutics, Inc. in connection with its $85 million acquisition of Relay Therapeutics, Inc.
  • Royalty Pharma in its $2.025 billion strategic financing partnership with MorphoSys
  • AbSci in its acquisition of Totient
  • Ascension Ventures in several venture investment deals in Vori Health, Cardionomic, CSA Medical, Cofactor Genomics, and others
  • Chiasma in its sale to Amryt Pharma
  • Forbion Capital Partners in venture investment deals in Rectify Pharmaceuticals and others
  • Disc Medicine, Inc. in its $90 million preferred stock financing
  • Clarus Therapeutics in its $25.3 million business combination with Blue Water Acquisition Corp., a special purpose acquisition company
  • Codiak Biosciences in connection with its sale of exosome manufacturing facility and assets to Lonza Rockland
  • Eluminex Biosciences in its acquisition of novel oral therapy assets and commercialization rights from Retinagenix Holdings, LLC
  • Smilegate Holdings, Inc. in $100 million venture investment in That’s No Moon Entertainment*
  • Senior management during the sale of Hansei Solutions, to Gulf Capital*
  • Senior management during the sale of Onica to Rackspace*
  • PROS Holdings, Inc. in $143 million convertible note offering*
  • Endologix, Inc., in $67 million convertible note offering*
  • Comcar Industries, Inc. in the successful sale of operating assets*
  • Otsuka America Pharmaceutical, Inc. in the purchase of the assets of Proteus Digital Health, Inc.*
  • Celadon Group in the sale of operating assets to Luminus Management*
  • Saybrook Corporate Opportunity Fund in connection with various portfolio companies, including financing matters, and sales and acquisitions*
  • Authentic Brands Group in the $271 million acquisition of Barneys New York’s intellectual property*
  • Network Global Logistics in the sale of its operating assets*

* Denotes experience prior to joining Goodwin.

Professional Experience

Prior to joining Goodwin, Ms. Ahmad was an associate at DLA Piper LLP (US) in Los Angeles.

Pro Bono

Ms. Ahmad also provides pro bono legal services, including through immigration and citizenship clinics, record expungement clinics, review of wrongful conviction case files, and advises non-profit organizations in connection with corporate governance matters. During her time at DLA Piper LLP, she also travelled to Nepal as part of a New Perimeter pro bono project to provide mentorship and legal education to women lawyers in Nepal.

In The News









LLM, 2016
University of California, Berkeley School of Law
LLB, 2011
University of London








Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique